Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fertilization in Vitro | 11 | 2022 | 83 | 3.100 |
Why?
|
Embryo Transfer | 7 | 2022 | 23 | 2.670 |
Why?
|
Anti-Mullerian Hormone | 7 | 2023 | 62 | 2.100 |
Why?
|
Placenta | 6 | 2022 | 55 | 2.050 |
Why?
|
Blastocyst | 3 | 2021 | 70 | 1.900 |
Why?
|
Infertility | 4 | 2023 | 30 | 1.640 |
Why?
|
Cryopreservation | 2 | 2024 | 27 | 1.550 |
Why?
|
Pregnancy Rate | 8 | 2023 | 29 | 1.520 |
Why?
|
Oocytes | 3 | 2024 | 193 | 1.490 |
Why?
|
Placenta Diseases | 2 | 2021 | 8 | 1.410 |
Why?
|
Reproductive Techniques, Assisted | 6 | 2022 | 31 | 1.360 |
Why?
|
Pregnancy Outcome | 6 | 2023 | 181 | 1.200 |
Why?
|
Live Birth | 4 | 2022 | 20 | 1.170 |
Why?
|
Pregnancy | 16 | 2024 | 2213 | 1.160 |
Why?
|
Oocyte Retrieval | 4 | 2021 | 12 | 1.120 |
Why?
|
Premature Birth | 3 | 2022 | 108 | 1.010 |
Why?
|
Fertilization | 3 | 2021 | 78 | 0.920 |
Why?
|
Semen | 2 | 2022 | 42 | 0.900 |
Why?
|
Follicular Fluid | 2 | 2021 | 14 | 0.900 |
Why?
|
Retrospective Studies | 14 | 2023 | 6071 | 0.790 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2022 | 35 | 0.750 |
Why?
|
Birth Weight | 5 | 2022 | 81 | 0.750 |
Why?
|
Ovarian Follicle | 2 | 2021 | 39 | 0.740 |
Why?
|
Infertility, Male | 1 | 2021 | 57 | 0.740 |
Why?
|
Semen Preservation | 1 | 2021 | 5 | 0.730 |
Why?
|
Phthalic Acids | 1 | 2021 | 36 | 0.730 |
Why?
|
Acetaminophen | 1 | 2021 | 49 | 0.720 |
Why?
|
Female | 26 | 2024 | 30724 | 0.680 |
Why?
|
Embryo Culture Techniques | 1 | 2020 | 10 | 0.680 |
Why?
|
Diabetes, Gestational | 1 | 2022 | 138 | 0.670 |
Why?
|
Pain Management | 1 | 2021 | 146 | 0.660 |
Why?
|
Adult | 16 | 2024 | 15683 | 0.630 |
Why?
|
Embryo, Mammalian | 1 | 2019 | 156 | 0.620 |
Why?
|
Spermatozoa | 1 | 2021 | 253 | 0.620 |
Why?
|
Cumulus Cells | 1 | 2018 | 6 | 0.600 |
Why?
|
In Vitro Oocyte Maturation Techniques | 1 | 2018 | 8 | 0.590 |
Why?
|
Preconception Care | 1 | 2017 | 23 | 0.570 |
Why?
|
Thrombosis | 1 | 2019 | 182 | 0.560 |
Why?
|
Weight Reduction Programs | 1 | 2017 | 55 | 0.550 |
Why?
|
Infant, Newborn | 6 | 2024 | 1284 | 0.500 |
Why?
|
Patient Compliance | 1 | 2017 | 349 | 0.490 |
Why?
|
Humans | 24 | 2024 | 59389 | 0.460 |
Why?
|
Ovulation Induction | 3 | 2023 | 12 | 0.420 |
Why?
|
Congenital Abnormalities | 2 | 2024 | 23 | 0.420 |
Why?
|
Abortion, Spontaneous | 3 | 2021 | 29 | 0.360 |
Why?
|
Polycystic Ovary Syndrome | 2 | 2021 | 22 | 0.360 |
Why?
|
Culture Media | 2 | 2022 | 77 | 0.330 |
Why?
|
Obesity | 1 | 2017 | 1166 | 0.330 |
Why?
|
Sperm Injections, Intracytoplasmic | 2 | 2021 | 32 | 0.330 |
Why?
|
Embryo Implantation | 2 | 2018 | 21 | 0.300 |
Why?
|
Young Adult | 4 | 2024 | 4272 | 0.270 |
Why?
|
Massachusetts | 2 | 2022 | 2019 | 0.250 |
Why?
|
Body Mass Index | 2 | 2020 | 831 | 0.240 |
Why?
|
Insemination, Artificial | 2 | 2023 | 3 | 0.240 |
Why?
|
Ovarian Reserve | 2 | 2021 | 8 | 0.230 |
Why?
|
Male | 8 | 2024 | 27747 | 0.230 |
Why?
|
Fertility Preservation | 1 | 2024 | 9 | 0.230 |
Why?
|
Infertility, Female | 2 | 2021 | 44 | 0.220 |
Why?
|
Leukemia | 1 | 2022 | 57 | 0.200 |
Why?
|
Time Factors | 2 | 2021 | 3615 | 0.190 |
Why?
|
Men | 1 | 2021 | 3 | 0.190 |
Why?
|
Perioperative Period | 1 | 2021 | 19 | 0.190 |
Why?
|
Mercury | 1 | 2021 | 7 | 0.190 |
Why?
|
Placebos | 1 | 2021 | 68 | 0.190 |
Why?
|
Administration, Intravenous | 1 | 2021 | 61 | 0.190 |
Why?
|
Gonadotropins | 1 | 2021 | 14 | 0.180 |
Why?
|
Semen Analysis | 1 | 2021 | 20 | 0.180 |
Why?
|
Cohort Studies | 3 | 2024 | 2375 | 0.180 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2021 | 36 | 0.180 |
Why?
|
Sperm Motility | 1 | 2021 | 47 | 0.180 |
Why?
|
Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2020 | 4 | 0.180 |
Why?
|
Weight Gain | 1 | 2022 | 163 | 0.180 |
Why?
|
Anovulation | 1 | 2020 | 10 | 0.180 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2021 | 35 | 0.180 |
Why?
|
Maternal Health | 1 | 2020 | 15 | 0.180 |
Why?
|
Fetal Resorption | 1 | 2020 | 1 | 0.170 |
Why?
|
Pregnancy, Twin | 1 | 2020 | 5 | 0.170 |
Why?
|
Infant, Premature | 1 | 2022 | 176 | 0.170 |
Why?
|
Pain, Postoperative | 1 | 2021 | 141 | 0.170 |
Why?
|
Pregnancy Complications | 1 | 2024 | 364 | 0.170 |
Why?
|
Pain Measurement | 1 | 2021 | 327 | 0.170 |
Why?
|
Time-Lapse Imaging | 1 | 2020 | 18 | 0.170 |
Why?
|
Progesterone | 1 | 2020 | 158 | 0.160 |
Why?
|
Double-Blind Method | 1 | 2021 | 715 | 0.160 |
Why?
|
Mullerian Ducts | 1 | 2019 | 4 | 0.160 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2019 | 29 | 0.160 |
Why?
|
Estradiol | 1 | 2020 | 247 | 0.160 |
Why?
|
Receptors, Peptide | 1 | 2019 | 31 | 0.160 |
Why?
|
Uterus | 1 | 2019 | 39 | 0.160 |
Why?
|
Adolescent | 2 | 2021 | 5838 | 0.160 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 725 | 0.160 |
Why?
|
Ambulatory Care | 1 | 2021 | 304 | 0.150 |
Why?
|
Time-to-Pregnancy | 1 | 2017 | 3 | 0.150 |
Why?
|
Surveys and Questionnaires | 1 | 2024 | 2516 | 0.130 |
Why?
|
Weight Loss | 1 | 2017 | 263 | 0.120 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 2380 | 0.120 |
Why?
|
Animal Communication | 1 | 2013 | 4 | 0.110 |
Why?
|
Smell | 1 | 2013 | 26 | 0.100 |
Why?
|
Primates | 1 | 2013 | 42 | 0.100 |
Why?
|
Lemuridae | 1 | 2012 | 1 | 0.100 |
Why?
|
Scent Glands | 1 | 2012 | 1 | 0.100 |
Why?
|
Bodily Secretions | 1 | 2012 | 1 | 0.100 |
Why?
|
Neoplasms | 1 | 2022 | 1231 | 0.100 |
Why?
|
Insemination | 2 | 2022 | 2 | 0.100 |
Why?
|
Biological Evolution | 1 | 2012 | 114 | 0.090 |
Why?
|
Gestational Age | 2 | 2021 | 178 | 0.080 |
Why?
|
Middle Aged | 1 | 2024 | 16314 | 0.070 |
Why?
|
Infant | 2 | 2022 | 1492 | 0.070 |
Why?
|
Logistic Models | 2 | 2020 | 1234 | 0.070 |
Why?
|
Maternal Age | 1 | 2024 | 32 | 0.060 |
Why?
|
Chorionic Gonadotropin | 1 | 2023 | 14 | 0.050 |
Why?
|
Risk Factors | 2 | 2024 | 4986 | 0.050 |
Why?
|
Child | 2 | 2022 | 4189 | 0.050 |
Why?
|
Clomiphene | 1 | 2021 | 2 | 0.050 |
Why?
|
Fertility Agents, Female | 1 | 2021 | 6 | 0.050 |
Why?
|
Pregnancy, Multiple | 1 | 2021 | 10 | 0.050 |
Why?
|
Reproduction | 1 | 2021 | 89 | 0.050 |
Why?
|
Follicle Stimulating Hormone | 1 | 2021 | 82 | 0.050 |
Why?
|
Infant, Low Birth Weight | 1 | 2021 | 56 | 0.040 |
Why?
|
Individuality | 1 | 2020 | 21 | 0.040 |
Why?
|
Ovary | 1 | 2021 | 98 | 0.040 |
Why?
|
Precision Medicine | 1 | 2020 | 102 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 674 | 0.040 |
Why?
|
Fertility | 1 | 2019 | 78 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 931 | 0.040 |
Why?
|
Base Sequence | 1 | 2019 | 1302 | 0.030 |
Why?
|
Prognosis | 1 | 2020 | 1597 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 718 | 0.030 |
Why?
|
Animals | 3 | 2019 | 19650 | 0.030 |
Why?
|
Olfactory Perception | 1 | 2012 | 3 | 0.030 |
Why?
|
Genitalia, Male | 1 | 2012 | 9 | 0.030 |
Why?
|
Genitalia, Female | 1 | 2012 | 17 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2012 | 41 | 0.020 |
Why?
|
Sexual Behavior, Animal | 1 | 2012 | 87 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 3231 | 0.020 |
Why?
|
Seasons | 1 | 2012 | 123 | 0.020 |
Why?
|
Species Specificity | 1 | 2012 | 329 | 0.020 |
Why?
|
Social Behavior | 1 | 2012 | 87 | 0.020 |
Why?
|
Phylogeny | 1 | 2012 | 337 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2012 | 197 | 0.020 |
Why?
|